[144] Phreesia, Inc. SEC Filing

Rhea-AI Filing Summary

Phreesia, Inc. (PHR) filed a Form 144 reporting a proposed sale of 93 common shares through Fidelity Brokerage Services with an aggregate market value of $2,226.29, slated for 09/18/2025. The filing shows those 93 shares were acquired by restricted stock vesting on 09/15/2025 (35 shares) and 09/16/2025 (58 shares) and were received as compensation. The issuer has 59,914,473 shares outstanding, so the proposed sale represents a de minimis fraction of the outstanding stock. The filing also lists multiple insider sales over the past three months, including larger transactions by David Linetsky (e.g., 23,729 shares on 06/27/2025 for $676,195.48). The notice includes the standard signer representations about absence of undisclosed material information.

Positive

• Clear disclosure of acquisition dates, nature of acquisition (restricted stock vesting), broker, and proposed sale details
• Proposed sale size is de minimis relative to total shares outstanding (93 shares vs. 59,914,473 outstanding)
• Past sales are itemized, providing transparency about recent insider transactions including dates and gross proceeds

Negative

• Insider selling activity in the past three months includes larger disposals (e.g., 23,729 shares on 06/27/2025 for $676,195.48), which may warrant investor attention
• No statement of a 10b5-1 trading plan date is provided in the remarks, so it is unclear whether the sales are pre-planned

Insights

Securities Analyst

TL;DR: Small proposed sale (93 shares, $2,226) from recently vested restricted stock; not material to capitalization but follows notable insider selling this year.

The Form 144 reports a routine sale of vested restricted shares that were acquired as compensation on 09/15/2025 and 09/16/2025. At 93 shares and $2,226 aggregate value against 59.9 million shares outstanding, this notice is immaterial to Phreesia's market capitalization. However, the filing should be read alongside disclosed insider disposals in the prior three months, notably a 23,729-share sale on 06/27/2025, which indicates ongoing insider liquidity events that investors may want to contextualize with trading plans and federal exemptions.

Compliance/Risk Analyst

TL;DR: Filing appears procedurally correct and includes signer representation; ensure timing aligns with Rule 144 requirements and any 10b5-1 plans.

The Form 144 furnishes acquisition dates, nature of acquisition (restricted stock vesting), broker details, and recent sale history, matching disclosure expectations. The filer attests to no undisclosed material information. From a compliance perspective, the close proximity of vesting and proposed sale dates is permissible but should be verified against any company blackout periods or pre-existing Rule 10b5-1 arrangements. No explicit plan dates are included in the remarks.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	93	2226.29	59914473	09/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2025	Restricted Stock Vesting	Issuer			35	09/15/2025	Compensation
Common	09/16/2025	Restricted Stock Vesting	Issuer			58	09/16/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jessica Weiss 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	06/18/2025	67	1715.96
David Linetsky 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	06/27/2025	23729	676195.48
David Linetsky 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/17/2025	2063	55465.41
Jessica Weiss 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	08/18/2025	78	2274.13
David Linetsky 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	08/22/2025	17445	518681.81
Jessica Weiss 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	09/16/2025	114	2654.42
David Linetsky 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	09/16/2025	2051	47756.30
David Linetsky 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	09/17/2025	1064	25004.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Phreesia's Form 144 (PHR) report for the proposed sale?

The filing reports a proposed sale of 93 common shares via Fidelity with aggregate market value $2,226.29, approximately to be sold on 09/18/2025.

How were the 93 shares acquired according to the Form 144?

The 93 shares were acquired by restricted stock vesting: 35 shares on 09/15/2025 and 58 shares on 09/16/2025, and the nature of payment is listed as compensation.

How large is the proposed sale relative to Phreesia's outstanding shares?

Phreesia has 59,914,473 shares outstanding; the proposed 93-share sale is a de minimis portion of the outstanding equity.

Does the filing show other insider sales recently?

Yes. The filing lists multiple insider sales in the past three months, including 23,729 shares sold by David Linetsky on 06/27/2025 for $676,195.48.

Who is the broker named in the proposed sale?

The broker listed is Fidelity Brokerage Services LLC at the Smithfield, RI address.